hospitalization in weeks. “It’s a miracle,” she said. “A vaccine—and the waiting room emptied.” In South Africa, young people now receive two-month HIV protection from a single shot. In London, bus drivers catch cancer before it catches them.
Here, research labs went dark. At Johns Hopkins, the neuroscience team studying childhood intellectual disabilities was told to shut off the lights. “I have startup funding,” said Dr. Anna Vlasits in Chicago. “But without NIH, I have no future.” That week, 340 grants were canceled at Harvard alone.
In North Carolina, cancer researcher Dr. Chrystal Starbird got the email: her grant panel was canceled. “They didn’t even bother with a reason. They’re shutting it down from the inside.”
By February, NIH had lost $4 billion. In April, 10,000 layoffs hit Health and Human Services. Some employees found out from 5 a.m. inbox alerts. Others discovered it when their badges stopped working. One woman, after 28 years of service, was turned away at the door. Her termination notice listed a complaint contact—someone who had died the year before.
“You don’t feel it until it’s you. Then it’s too late.”
In Manchester, a 58-year-old bus driver named Jeanette stepped into a mobile cancer van during lunch. She felt fine. The test said otherwise. “They caught it early. I met my granddaughter because of that van.” The test, called Galleri, is part of a UK pilot program screening for over 50 cancers with a single blood draw. In America, that kind of innovation isn’t expanding. It’s vanishing.
Dr. Paula Castaño had to shut down two contraceptive trials midstream. “People think these cuts hit elite institutions. But my patients are being hurt.”
At the CDC, every first-year epidemic intelligence officer—the country’s outbreak investigators—was laid off.
“Losing them isn’t just tragic. It’s suicide.”
Elsewhere, health still means hope. In Pakistan, field workers who once dodged roadblocks and conspiracy theories are now called “daughters of hope.” In 2025, only seven cases of wild polio were reported worldwide. In Bangladesh, mobile midwives help mothers survive childbirth with portable kits and video calls. In Portugal, mental health waitlists are disappearing. In Canada, therapists are embedded into routine care.
Here, Title X is gutted. LGBTQ+ health programs are being stripped. Over 20 states have banned gender-affirming care. Even the CDC is barred from issuing vaccine guidance. New rules block the collection of gender identity data. If you can’t count a population, you can’t serve it.
“If your health is politicized, your survival is too.”
And yet, the technology keeps arriving.
In Montana, a surgeon in Seattle performed a robotic procedure 700 miles away with near-zero latency. In Chicago, a woman recovered from surgery in her living room, monitored by a smartwatch and a nurse on screen. In Boston, an AI flagged a leukemia diagnosis the human eye missed. “I didn’t trust it at first,” said Dr. Emily Chen. “Now, I don’t work without it.”
But innovation doesn’t mean progress. Not when the scaffolding is gone.
The U.S. led the COVID vaccine race. It built mRNA platforms, public-private alliances,